Review



simcyp© pregnancy population model  (Simcyp)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Simcyp simcyp© pregnancy population model
    Simcyp© Pregnancy Population Model, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/simcyp+simulator/pm38140068-281-13-12
    Average 90 stars, based on 1 article reviews
    simcyp© pregnancy population model - by Bioz Stars, 2026-11
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments
    Article Snippet: Although the pharmacokinetic processes relevant for doravirine are longitudinally described and validated in the pregnancy Simcyp model, we believe some caution in data interpretation is still needed.



    Similar Products

    simcyp© pregnancy population model  (Simcyp)
    90
    Simcyp simcyp© pregnancy population model
    Simcyp© Pregnancy Population Model, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/simcyp+simulator/pm38140068-281-13-12
    Average 90 stars, based on 1 article reviews
    simcyp© pregnancy population model - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    pregnancy model simcyp v21  (Simcyp)
    90
    Simcyp pregnancy model simcyp v21
    Pregnancy Model Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/v21/pmc10748010-82-2-4
    Average 90 stars, based on 1 article reviews
    pregnancy model simcyp v21 - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    pregnancy pbpk model simcyp v21  (Simcyp)
    90
    Simcyp pregnancy pbpk model simcyp v21
    Pregnancy Pbpk Model Simcyp V21, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/13+compartment+full+pbpk+model+simcyp++population+based+simulator+version+12+1/pmc10609738-81-1-8
    Average 90 stars, based on 1 article reviews
    pregnancy pbpk model simcyp v21 - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    full-body simcyp pregnancy pbpk model  (Simcyp)
    90
    Simcyp full-body simcyp pregnancy pbpk model
    Parameters of the mechanistic placenta model
    Full Body Simcyp Pregnancy Pbpk Model, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/simcyp+pbpk+model/pmc09349081-55-23-24
    Average 90 stars, based on 1 article reviews
    full-body simcyp pregnancy pbpk model - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    pregnancy simcyp model  (Simcyp)
    90
    Simcyp pregnancy simcyp model
    Parameters of the mechanistic placenta model
    Pregnancy Simcyp Model, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/simcyp+pregnancy+model/pmc09349081-180-14-15
    Average 90 stars, based on 1 article reviews
    pregnancy simcyp model - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier
    simcyp pregnancy model  (Simcyp)
    90
    Simcyp simcyp pregnancy model
    Parameters of the mechanistic placenta model
    Simcyp Pregnancy Model, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pregnancy+simcyp+model/simcyp+pregnancy+model/pm33851424-60-1-1
    Average 90 stars, based on 1 article reviews
    simcyp pregnancy model - by Bioz Stars, 2026-11
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Parameters of the mechanistic placenta model

    Journal: Clinical Pharmacokinetics

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

    doi: 10.1007/s40262-022-01127-0

    Figure Lengend Snippet: Parameters of the mechanistic placenta model

    Article Snippet: Therefore, the primary study aim was to predict maternal and fetal doravirine exposure by integrating data from human placenta perfusion experiments in a full-body Simcyp pregnancy PBPK model. To do so, we describe a method for parameterization of the permeability-limited placenta model in Simcyp.

    Techniques:

    Structure of the pregnancy physiologically based pharmacokinetic (PBPK) model in the PBPK platform Simcyp

    Journal: Clinical Pharmacokinetics

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

    doi: 10.1007/s40262-022-01127-0

    Figure Lengend Snippet: Structure of the pregnancy physiologically based pharmacokinetic (PBPK) model in the PBPK platform Simcyp

    Article Snippet: Therefore, the primary study aim was to predict maternal and fetal doravirine exposure by integrating data from human placenta perfusion experiments in a full-body Simcyp pregnancy PBPK model. To do so, we describe a method for parameterization of the permeability-limited placenta model in Simcyp.

    Techniques:

    Predicted mean doravirine total plasma concentration at steady state after treatment with A , B doravirine 100 mg QD or C , D 100 mg BID using the pregnancy physiologically based pharmacokinetic model ( n = 100 subjects). The in vivo target of 0.23 mg/L was derived from in vivo exposure–response analysis . BID twice daily, QD once daily, w weeks

    Journal: Clinical Pharmacokinetics

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

    doi: 10.1007/s40262-022-01127-0

    Figure Lengend Snippet: Predicted mean doravirine total plasma concentration at steady state after treatment with A , B doravirine 100 mg QD or C , D 100 mg BID using the pregnancy physiologically based pharmacokinetic model ( n = 100 subjects). The in vivo target of 0.23 mg/L was derived from in vivo exposure–response analysis . BID twice daily, QD once daily, w weeks

    Article Snippet: Therefore, the primary study aim was to predict maternal and fetal doravirine exposure by integrating data from human placenta perfusion experiments in a full-body Simcyp pregnancy PBPK model. To do so, we describe a method for parameterization of the permeability-limited placenta model in Simcyp.

    Techniques: Clinical Proteomics, Concentration Assay, In Vivo, Derivative Assay

    Sensitivity analysis of the estimated placental parameters using the pregnancy physiologically based pharmacokinetic model ( n = 100 subjects). Sensitivity of CL pdm input on the doravirine A maternal plasma concentration and B fetal venous blood concentration. Sensitivity of CL pdf input on the doravirine, C maternal plasma concentration and D fetal venous blood concentration. The 2.5th and 97.5th percentile of the typical CL pdf and CL pdm are estimated with the mechanistic placenta model. Sensitivity of the FUp impute on the doravirine, E maternal plasma concentration and F fetal venous blood concentration. Sensitivity of the experimental placenta perfusion configuration on the doravirine, G maternal plasma concentration and H fetal venous blood concentration. CL pdf clearance between fetal part of the placenta and the placental barrier, CL pdm clearance between maternal part of the placenta and the placental barrier, FU P fraction unbound in the placental barrier

    Journal: Clinical Pharmacokinetics

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

    doi: 10.1007/s40262-022-01127-0

    Figure Lengend Snippet: Sensitivity analysis of the estimated placental parameters using the pregnancy physiologically based pharmacokinetic model ( n = 100 subjects). Sensitivity of CL pdm input on the doravirine A maternal plasma concentration and B fetal venous blood concentration. Sensitivity of CL pdf input on the doravirine, C maternal plasma concentration and D fetal venous blood concentration. The 2.5th and 97.5th percentile of the typical CL pdf and CL pdm are estimated with the mechanistic placenta model. Sensitivity of the FUp impute on the doravirine, E maternal plasma concentration and F fetal venous blood concentration. Sensitivity of the experimental placenta perfusion configuration on the doravirine, G maternal plasma concentration and H fetal venous blood concentration. CL pdf clearance between fetal part of the placenta and the placental barrier, CL pdm clearance between maternal part of the placenta and the placental barrier, FU P fraction unbound in the placental barrier

    Article Snippet: Therefore, the primary study aim was to predict maternal and fetal doravirine exposure by integrating data from human placenta perfusion experiments in a full-body Simcyp pregnancy PBPK model. To do so, we describe a method for parameterization of the permeability-limited placenta model in Simcyp.

    Techniques: Clinical Proteomics, Concentration Assay

    Journal: Clinical Pharmacokinetics

    Article Title: Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

    doi: 10.1007/s40262-022-01127-0

    Figure Lengend Snippet:

    Article Snippet: Therefore, the primary study aim was to predict maternal and fetal doravirine exposure by integrating data from human placenta perfusion experiments in a full-body Simcyp pregnancy PBPK model. To do so, we describe a method for parameterization of the permeability-limited placenta model in Simcyp.

    Techniques: Derivative Assay